v3 Template
D

DaltonTx

Biotechnology / Drug Discovery ~300 employees
Founded
--
Employees (Est.)
~300
15 leaders known
Total Funding
$5.0M
Funding Rounds
1
Last Funding
2025-09-23

About DaltonTx

DaltonTx is redefining how technology powers drug discovery, creating the intelligence backbone for tomorrow's medicines. Their AI-enabled platforms provide essential infrastructure for pharma, biotech, and CROs, transforming the economics, timelines, and outcomes of R&D. Their adaptive intelligent system evolves with science, integrates into workflows, and delivers lasting capability by learning from scientists, models, and experiments.

Products & Services

AI Cloud Platform:A purpose-built platform for creating AI-enabled drug discovery capabilities for both biologics and small molecules.
Collaborative Intelligence System:Fuses human expertise with machine intelligence to continuously improve drug discovery processes.
Adaptive Technology:Learns from every scientist, model, and experiment, getting smarter over time to guide better decisions.
Comprehensive Discovery Lifecycle Tools:Covers the full discovery lifecycle, including data ingestion, model training, molecule generation, and experiment prioritization.
Secure Cloud-Native Infrastructure:Designed to fit various environments and scale as scientific advancements occur.

Specialties

AI in Drug Discovery Machine Learning Software Engineering Small Molecules Biologics

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Seed
T: -
FT: Seed
A: 5000000
MR: -
FA: £4 million
FAN: 5000000
D: 2025-09-23
FD: 2025-09-23
3 investors
Seed Latest
2025-09-23
$5.0M
3 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

Dr. Garry Pairaudeau

CEO and Co-Founder

D

Dr. Anthony Bradley

CSO and Co-Founder

P

Professor Charlotte Deane MBE

CAIO and Co-Founder

A

Adrian Rossall

CTO and Co-Founder

D

Dr. Fergus Boyles

A

Adelize van Eeden

View 12 more team members with Pro

Unlock Full Team Directory

Recent News

DaltonTx Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Drug Discovery
Company Size
~300 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro